An Examination of Claims-based Predictors of Overdose from a Large Medicaid Program

Medical Care

Volumn 55, Issue 3, 2017, Pages 291-298

  Cochran, Gerald ^a,b   Gordon, Adam J ^a,c,d   Lo Ciganic, Wei Hsuan ^e   Gellad, Walid F ^a,c,d   Frazier, Winfred ^d   Lobo, Carroline ^f   Chang, Chung Chou H ^d,f   Zheng, Ping ^f   Donohue, Julie M ^a,f  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b Section of Pulmonary and Critical Care Medicine   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF ARIZONA   (United States)

^f UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

health claims; opioid medication misuse and abuse; opioid medication overdose

Indexed keywords

MUSCLE RELAXANT AGENT; OPIATE; NARCOTIC ANALGESIC AGENT;

ADULT; ANXIETY DISORDER; ARTICLE; BILLING AND CLAIMS; CANCER DIAGNOSIS; COHORT ANALYSIS; COMPARATIVE STUDY; DRUG INTOXICATION; DRUG MISUSE; DRUG USE; FEMALE; HEALTH PROGRAM; HOSPICE CARE; HUMAN; ICD-9; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAID; MOOD DISORDER; PENNSYLVANIA; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; UNITED STATES; ADOLESCENT; AGE; CLINICAL PRACTICE; COMORBIDITY; DEMOGRAPHY; DRUG OVERDOSE; INSURANCE; MIDDLE AGED; OPIOID-RELATED DISORDERS; PHARMACY; SEX DIFFERENCE; SOCIOECONOMICS; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; ANALGESICS, OPIOID; COMORBIDITY; DRUG OVERDOSE; FEMALE; HUMANS; INSURANCE CLAIM REVIEW; LONGITUDINAL STUDIES; MALE; MEDICAID; MIDDLE AGED; OPIOID-RELATED DISORDERS; PENNSYLVANIA; PHARMACIES; PRACTICE PATTERNS, PHYSICIANS'; RESIDENCE CHARACTERISTICS; RETROSPECTIVE STUDIES; SEX FACTORS; SOCIOECONOMIC FACTORS; UNITED STATES; YOUNG ADULT;

EID: 85012914598     PISSN: 00257079     EISSN: 15371948     Source Type: Journal    
DOI: 10.1097/MLR.0000000000000676     Document Type: Article

References (50)

1. Rudd R, Aleshire N, Zibbell J, et al. Increases in Drug and Opioid Overdose Deaths-United States, 2000-2014. Atlanta, GA: Centers for Disease Control and Prevention; 2015.
2. Centers for Disease Control and Prevention. Prescription drug overdose data: deaths from prescription opioid overdose. 2015. Available at: www.cdc.gov/drugoverdose/data/overdose.html. Accessed July 16, 2015.
3. White House. Obama Administration Announces Public and Private Sector Efforts to Address Prescription Drug Abuse and Heroin Use [press release]. Washington, DC: Office of the Press Secretary. 2015.
4. Haegerich TM, Paulozzi LJ, Manns BJ, et al. What we know, and don't know, about the impact of state policy and systems-level interventions on prescription drug overdose. Drug Alcohol Depend. 2014;145:34-47.
5. Logan J, Liu Y, Paulozzi L, et al. Opioid prescribing in emergency departments: the prevalence of potentially inappropriate prescribing and misuse. Med Care. 2013;51:646-653.
6. Mack KA, Zhang K, Paulozzi L, et al. Prescription practices involving opioid analgesics among Americans with Medicaid, 2010. J Health Care Poor Underserved. 2015;26:182-198.
7. Liu Y, Logan JE, Paulozzi LJ, et al. Potential misuse and inappropriate prescription practices involving opioid analgesics. Am J Manag Care. 2013;19:648-665.
8. Bohnert ASB, Valenstein M, Bair MJ, et al. Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA. 2011;305:1315-1321.
9. Paulozzi LJ, Strickler GK, Kreiner PW, et al. Controlled substance prescribing patterns-prescription behavior surveillance system, eight states, 2013. Surveillance summaries. MMWR Morb Mortal Wkly Rep. 2015;64:1-14.
10. Dasgupta N, Funk MJ, Proescholdbell S, et al. Cohort study of the impact of high-dose opioid analgesics on overdose mortality. Pain Med. 2015;17:85-98.
11. Gwira Baumblatt JA, Wiedeman C, Dunn JR, et al. High-risk use by patients prescribed opioids for pain and its role in overdose deaths. JAMA Intern Med. 2014;174:796-801.
12. Dunn KM, Saunders KW, Rutter CM, et al. Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med. 2010;152:85-92.
13. Cochran G, Woo B, Lo-Ciganic W-H, et al. Defining nonmedical use of prescription opioids within health care claims: a systematic review. Subst Abus. 2015;36:192-202.
14. Barrett SP, Meisner JR, Stewart SH. What constitutes prescription drug misuse? Problems and pitfalls of current conceptualizations. Curr Drug Abuse Rev. 2008;1:255-262.
15. Compton WM, Volkow ND. Abuse of prescription drugs and the risk of addiction. Drug Alcohol Depend. 2006;83(suppl 1):S4-S7.
16. White AG, Birnbaum HG, Schiller M, et al. Analytic models to identify patients at risk for prescription opioid abuse. Am J Manag Care. 2009;15:897-906.
17. Rice JB, White AG, Birnbaum HG, et al. A model to identify patients at risk for prescription opioid abuse, dependence, and misuse. Pain Med. 2012;13:1162-1173.
18. Sullivan MD, Edlund MJ, Fan M-Y, et al. Risks for possible and probable opioid misuse among recipients of chronic opioid therapy in commercial and Medicaid insurance plans: the TROUP Study. Pain. 2010;150:332-339.
19. Substance Abuse and Mental Health Services Administration. Results From the 2013 National Survey on Drug Use and Health: Summary of National Findings. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2014.
20. Morden NE, Zerzan JT, Rue TC, et al. Medicaid prior authorization and controlled-release oxycodone. Med Care. 2008;46:573-580.
21. Centers for Medicare and Medicaid Services. Best Practices for Addressing Prescription Opioid Overdoses, Misuse and Addiction. Baltimore, MD: Centers for Medicare and Medicaid Services; 2016.
22. Centers for Disease Control. Prevention Status Report 2013: Prescription Drug Overdose. Pennsylvania. Atlanta, GA: Centers for Disease Control; 2013.
23. Melfi CA, Croghan TW. Use of claims data for research on treatment and outcomes of depression care. Med Care. 1999;37(suppl Lilly): As77-As80.
24. Hornbrook MC, Hurtado AV, Johnson RE. Health care episodes: definition, measurement and use. Med Care Res Rev. 1985;42:163-218.
25. World Health Organization. International Statistical Classification of Diseases and Related Health Problems 9th Edition (ICD-9). Geneva: World Health Organization; 2011.
26. Unick GJ, Rosenblum D, Mars S, et al. Intertwined epidemics: national demographic trends in hospitalizations for heroin- and opioid-related overdoses, 1993-2009. Plos One. 2013;8:e54496.
27. Darke S, Mattick RP, Degenhardt L. The ratio of non-fatal to fatal heroin overdose. Addiction. 2003;98:1169-1171.
28. Prescription Drug Monitoring Program training and Technical Assistance Center. Technical Assistance Guide No 01-13, Calculating Daily Morphine, Milligram Equivalents. Boston, MA: Brandeis University, The Heller School for Policy and Management; 2013.
29. United States Department of Agriculture. Rural-urban continuum codes. 2013. Available at: www.ers.usda.gov/data-products/rural-urban-contin-uum-codes/documentation.aspx#.VC61zGddUrA. Accessed October 3, 2014.
30. Baldwin LM, Andrilla CH, Porter MP, et al. Treatment of early-stage prostate cancer among rural and urban patients. Cancer. 2013;119:3067-3075.
31. Sullivan MD, Edlund MJ, Fan M-Y, et al. Trends in use of opioids for non-cancer pain conditions 2000-2005 in Commercial and Medicaid insurance plans: the TROUP study. Pain. 2008;138:440-449.
32. SAS Institute Inc.. SAS/STAT(R) 922 Users Guide, The GENMOD Procedure. Cary, NC: SAS Institute Inc.; 2010.
33. SAS 9.4 [computer program]. Cary, NC, 2013.
34. Chang Y-P, Compton P. Management of chronic pain with chronic opioid therapy in patients with substance use disorders. Addict Sci Clin Pract. 2013;8:21.
35. Savage SR, Kirsh KL, Passik SD. Challenges in using opioids to treat pain in persons with substance use disorders. Addict Sci Clin Pract. 2008;4:4-25.
36. Nuckols TK, Anderson L, Popescu I, et al. Opioid prescribing: a systematic review and critical appraisal of guidelines for chronic pain. Ann Intern Med. 2014;160:38-47.
37. Roberts AW, Skinner AC. Assessing the present state and potential of Medicaid controlled substance lock-in programs. J Manag Care Spec Pharm. 2014;20:439-446.
38. Centers for Disease Control and Prevention. Patient Review & Restriction Programs Lessons learned from state Medicaid programs. Atlanta, GA: Centers for Disease Control and Prevention; 2012.
39. Centers for Medicare and Medicaid Services. Drug Diversion in the Medicaid Program: State Strategies for Reducing Prescription Drug Diversion in Medicaid. Baltimore, MD: Department of Health and Human Services, Centers for Medicare and Medicaid Services, Center for Program Integrity; 2012.
40. Alford DP. Opioid prescribing for chronic pain-achieving the right balance through education. N Engl J Med. 2016;374:301-303.
41. Cicero TJ, Ellis MS, Surratt HL, et al. The changing face of heroin use in the United States: a retrospective analysis of the past 50 years. JAMA Psychiatry. 2014;71:821-826.
42. Cicero TJ, Ellis MS. Abuse-deterrent formulations and the prescription opioid abuse epidemic in the United States: lessons learned from OxyContin. JAMA Psychiatry. 2015;72:424-430.
43. Hall AJ, Logan JE, Toblin RL, et al. Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA. 2008;300: 2613-2620.
44. Webster LR, Cochella S, Dasgupta N, et al. An analysis of the root causes for opioid-related overdose deaths in the United States. Pain Med. 2011;12(suppl 2):S26-S35.
45. Centers for Disease Control and Prevention. Overdose deaths involving prescription opioids among Medicaid enrollees-Washington, 2004-2007. MMWR Morb Mortal Wkly Rep. 2009;58:1171-1175.
46. Centers for Disease Control and Prevention. Health, United States 2012: With Special Feature on Emergency Care. Hyattsville, MD: Centers for Disease Control; 2013.
47. Dartmouth. The Dartmouth atlas of health care. 2014. Available at: www.dartmouthatlas.org/. Accessed March 8, 2014.
48. Pating DR, Miller MM, Goplerud E, et al. New systems of care for substance use disorders: treatment, finance, and technology under health care reform. Psychiatr Clin North Am. 2012;35:327-356.
49. Kim HM, Smith EG, Stano CM, et al. Validation of key behaviourally based mental health diagnoses in administrative data: suicide attempt, alcohol abuse, illicit drug abuse and tobacco use. BMC Health Serv Res. 2012;12:1-9.
50. Viswanathan M, Kahwati LC, Golin CE, et al. Medication therapy management interventions in outpatient settings: a systematic review and meta-analysis. JAMA Intern Med. 2015;175:76-87.